ஜெநெடிக் பயோமார்க்ஸ் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ஜெநெடிக் பயோமார்க்ஸ். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ஜெநெடிக் பயோமார்க்ஸ் Today - Breaking & Trending Today

Worldwide Precision Psychiatry Industry to 2026 - by Product Type, Biomarker Type, Sample, Technology, Application, End-user and Region


Global Increase in Mental Health Burden
Market Challenges
Lack of Awareness for Precision Psychiatry Diagnostics
Market Opportunities
Massive Scope for Adoption of NGS-Based Genetic Tests in Emerging Markets
Key Companies Profiled
Illumina, Inc., F. Hoffmann-La Roche Ltd., Bio-Rad Laboratories, Inc., QIAGEN N.V., Quest Diagnostics Incorporated, ARUP Laboratories, Invitae Corporation, OPKO Health, Inc., Laboratory Corporation of America Holdings, Centogene N.V., Thermo Fisher Scientific Inc., Myriad Genetics, Inc., Konica Minolta, Inc., Fulgent Genetics, PreventionGenetics
Key Questions Answered in this Report:
How is precision psychiatry revolutionizing the field of mental health diagnostics?
What are the major market drivers, challenges, and opportunities in the global precision psychiatry market? ....

United States , United Kingdom , South Korea , Laura Wood , Precision Diagnostics For Drug Development , Role Of Invitae Corporation Inc , Quest Diagnostics Incorporated , Role Of Bio Rad Laboratories Inc , Health Inc , Invitae Corporation , Global Increase In Mental Health Burden , Konica Minolta Inc , Roche Ltd , Role Of Myriad Genetics Inc , Company Overview , Office Hours Call , Laboratory Corporation Of America Holdings , Criteria For Company , Financial Health Of The Company , Research Methodology , Role Of Laboratory Corporation America Holdings , Role Of Konica Minolta Inc , Company Profiles , Bio Rad Laboratories Inc , E St Office Hours Call , Genetics Inc ,

Cancer Biomarkers Market Size Worth over $26,979.50 million by 2027, at CAGR 11.8%


Search jobs
Cancer Biomarkers Market Size Worth over $26,979.50 million by 2027, at CAGR 11.8%
Pune, Maharashtra, India, February 18 2021 (Wiredrelease) Allied Analytics –:Prevalence of various types of cancers such as breast, prostate, and lung cancer, development of biological & targeted drug therapies, and reliability of cancer biomarkers fuel the growth of the global cancer biomarkers market. On the other hand, high cost of drug development, threat of failure associated with cancer treatment, and unregulated government regulations & reimbursement policies impede the growth to some extent. However, high-end technological advancements are expected to create multiple opportunities in the industry.
Allied Market Research published a report titled, “Cancer Biomarkers Market size is expected to reach $26,979.50 million by 2027, registering a CAGR of 11.8% from 2020 to 2027, in terms of value. North America and Europe are the most lucrative ....

United States , Hong Kong , United Kingdom , David Correa , Roche Ltd , Business Intelligence Solutions , Bristol Myers Squibb Company , Perkinelmer Inc , Wiredrelease News Department , Bio Rad Laboratories Inc , Market Research , Merck Kga , Merck Kgaa , Thermo Fisher Scientific Inc , Abbott Laboratories , Technology Omic Technologies , Sciences Corporation , Allied Analytics , Biomarkers Market , Profiling Technology , Omic Technologies , Imaging Technologies , Cytogenetics Based Tests , Genetic Biomarkers , Protein Biomarkers , Cancer Type ,